Implementation of Supportive Sling Device in Adults Post-stroke for Prevention of Shoulder Complications

University Hospital, Toulouse25 enrolled

Overview

Upper limb (UL) impairment is a common deficit following stroke with only an estimated 20 per cent of patients recovering function.

Upper limb (UL) impairment is a common deficit following stroke with only an estimated 20 per cent of patients recovering function. Pain associated with UL impairment due to multifactorial causes is a frequent symptom in patients with stroke. Occupational therapy techniques focus on the implementation of positioning techniques and the use of supportive devices (SD) such as slings aimed to prevent pain; therefore increase daily function, participation and hence quality of life. At present, positioning principles of the hemiplegic shoulder exist in clinical practice. These are aimed at prevention of pain associated with UL Impairment; however there is no clear consensus among professionals of particular SD that should be implemented for adults with stroke

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Cerebrovascular Accident

Interventions

Evaluate the effects of the EO31 shoulder sling in adults post-stokeDEVICE

Investigator want to evaluate the efficient of the EO31 shoulder sling in adults post-stroke. The EO31 shoulder sling is made-to-measure shoulder pads for upper limb after cerebrovascular accident

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Having suffered in the last 6 months maximum a first stroke responsible for hemiplegia. * Finding a clinical 5mm appendix, or with shoulder pain requiring prescription a scarf. * Boston Diagnostic Aphasia Examination (BDAE) \> 3. * Consent of the patient * Patient affiliated or benefiting from a social security scheme Exclusion Criteria: * Stroke recurrence, or stroke more than 6 months-old * Patient already wearing a coaptation scarf * Presence of lymphoedema, venous thrombosis of the upper limb * Neoprene allergy * Severe cognitive impairment: Mini-Mental State (MMS) \<15 * Patient being part of another care protocol * Adult under the protection of justice, tutors or curators * Pregnant or lactating woman.

Locations (1)

CHU de Toulouse

Toulouse, France

Outcomes

Primary Outcomes

Evaluate the effects of the EO31 shoulder with Goal Attainment Scale (GAS) scale

GAS (Goal Attainment Scale) scores will be described with regards to the 3 client-centred objectives. The score for each objective is comprised between -2 (when objective is not achieve) to 2 (achieve objective).

Time frame: 5 weeks

Secondary Outcomes

Evaluate shoulder pain with Visual Analog Scale for Pain (EVA scale)

The shoulder pain will be evaluate with th sling with EVA Scale. Eva scale is between 0 (no pain) to 10 (big pain)

Time frame: 24 hours

Evaluate shoulder pain with EVA scale

The shoulder pain will be evaluate with th sling with EVA Scale. Eva scale is between 0 (no pain) to 10 (big pain).

Time frame: 5 weeks

Evaluate shoulder pain with EVA scale

The shoulder pain will be evaluate with th sling with EVA Scale. Eva scale is between 0 (no pain) to 10 (big pain).

Time frame: baseline

Spasticity with TARDIEU scale

Evaluate the spasticity of upper limb with TARDIEU scale: the rotation angle of the shoulder, elbow and wrist are measured

Time frame: baseline

Spasticity with TARDIEU scale

Evaluate the spasticity of upper limb with TARDIEU scale: the rotation angle of the shoulder, elbow and wrist are measured

Time frame: 7 days

Spasticity with TARDIEU scale

Evaluate the spasticity of upper limb with TARDIEU scale: the rotation angle of the shoulder, elbow and wrist are measured

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.